Mary Beth Terry

30.6k total citations · 1 hit paper
390 papers, 11.1k citations indexed

About

Mary Beth Terry is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Mary Beth Terry has authored 390 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Oncology, 106 papers in Genetics and 96 papers in Molecular Biology. Recurrent topics in Mary Beth Terry's work include Cancer Risks and Factors (114 papers), Global Cancer Incidence and Screening (71 papers) and BRCA gene mutations in cancer (68 papers). Mary Beth Terry is often cited by papers focused on Cancer Risks and Factors (114 papers), Global Cancer Incidence and Screening (71 papers) and BRCA gene mutations in cancer (68 papers). Mary Beth Terry collaborates with scholars based in United States, Canada and Australia. Mary Beth Terry's co-authors include Regina M. Santella, Alfred I. Neugut, Marilie D. Gammon, Parisa Tehranifar, Susan L. Teitelbaum, Julie D. Flom, Rebecca D. Kehm, Yuyan Liao, Mia M. Gaudet and Ruby T. Senie and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Mary Beth Terry

370 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns

2021 166 citations Sarah M. Lima, Rebecca D. Kehm et al. profile →

Peers

Countries citing papers authored by Mary Beth Terry

Since Specialization

Citations

This map shows the geographic impact of Mary Beth Terry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beth Terry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beth Terry more than expected).

Fields of papers citing papers by Mary Beth Terry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Beth Terry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beth Terry. The network helps show where Mary Beth Terry may publish in the future.

Co-authorship network of co-authors of Mary Beth Terry

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Beth Terry. A scholar is included among the top collaborators of Mary Beth Terry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Beth Terry. Mary Beth Terry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early onset cancer trends and the persistently higher burden of cancer in young women 2025 ·The Oncologist ·Rebecca D. Kehm, Mary Beth Terry	2
2	The Persistent Poverty Initiative’s Framework to Address Social and Economic Determinants of Cancer 2025 ·Cancer Epidemiology Biomarkers & Prevention ·Robert A. Hiatt, Amy E. Kennedy, (unknown), Karen Basen‐Engquist, Melissa L. Bondy, Luis G. Carvajal‐Carmona, Mona N. Fouad, David B. Grusky, Alicia K. Matthews, Lorna H. McNeill, Erica Phillips, Laura C. Pinheiro, (unknown), Ruth Rechis, David H. Rehkopf, Rulla M. Tamimi, Mary Beth Terry, David W. Wetter, Shobha Srinivasan	0
3	Quantifying work-related social inequalities in life expectancy: a methodological proof of concept 2024 ·American Journal of Epidemiology ·(unknown), Mary Beth Terry, Émilie Counil	1
4	Plasma metabolomics profiles and breast cancer risk 2024 ·Breast Cancer Research ·Hui-Chen Wu, Yunjia Lai, Yuyan Liao, Maya A. Deyssenroth, Gary W. Miller, Regina M. Santella, Mary Beth Terry	4
5	Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Danielle E. Haslam, Esther M. John, Julia A. Knight, (unknown), Saundra S. Buys, Irene L. Andrulis, Mary B. Daly, Jeanine M. Genkinger, Mary Beth Terry, Fang Fang Zhang	4
6	Risk factors for developing both primary breast and primary ovarian cancer: A systematic review 2023 ·Critical Reviews in Oncology/Hematology ·Jennifer S. Ferris, (unknown), (unknown), Mary Beth Terry, Ruth Ottman, Chin Hur, Jason D. Wright, Jeanine M. Genkinger	7
7	Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City 2022 ·Journal of Community Genetics ·Sarah M. Lima, (unknown), Karen M. Schmitt, Andria Reyes, Elaine Fleck, Gary K. Schwartz, Mary Beth Terry, Grace Clarke Hillyer	0
8	E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk 2021 ·Journal of Community Health ·Grace Clarke Hillyer, (unknown), Sarah M. Lima, Karen M. Schmitt, Andria Reyes, Elaine Fleck, Gary K. Schwartz, Mary Beth Terry	3
9	A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families 2021 ·Statistical Methods in Medical Research ·Yun‐Hee Choi, (unknown), Saundra S. Buys, Mary B. Daly, Esther M. John, John L. Hopper, Irene L. Andrulis, Mary Beth Terry, Laurent Briollais	1
10	Reproductive and environmental exposures and the breast cancer risk in Taiwanese women 2021 ·Scientific Reports ·Hui‐Chen Wu, Hwai‐I Yang, Po‐Han Lin, Chien‐Jen Chen, Regina M. Santella, Mary Beth Terry	3
11	Long-term PM2.5 exposure before diagnosis is associated with worse outcome in breast cancer 2021 ·Breast Cancer Research and Treatment ·Diddier Prada, Andrea Baccarelli, Mary Beth Terry, (unknown), (unknown), Allan C. Just, Itai Kloog, (unknown), Claudia M. García-Cuéllar, Yesennia Sánchez-Pérez, (unknown), José Díaz‐Chávez, (unknown), (unknown), Abelardo Meneses-García, David Cantú de León, Luis A. Herrera, Enrique Bargalló	15
12	Menopausal hormone therapy use and long‐term all‐cause and cause‐specific mortality in the Long Island Breast Cancer Study Project 2020 ·International Journal of Cancer ·Tengteng Wang, Patrick T. Bradshaw, Patricia G. Moorman, Sarah J. Nyante, Hazel B. Nichols, Sumitra Shantakumar, Humberto Parada, Nikhil K. Khankari, Mary Beth Terry, Susan L. Teitelbaum, Alfred I. Neugut, Marilie D. Gammon	5
13	Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients 2020 ·Clinical Trials ·Grace Clarke Hillyer, Melissa Beauchemin, Dawn L. Hershman, (unknown), Frances Brogan, (unknown), Karen M. Schmitt, Andria Reyes, Mary Beth Terry, Andrew B. Lassman, Gary K. Schwartz	22
14	Community education to enhance the more equitable use of precision medicine in Northern Manhattan 2020 ·Journal of Genetic Counseling ·Grace Clarke Hillyer, Karen M. Schmitt, Andria Reyes, Alejandro Francisco‐Cruz, (unknown), Gary K. Schwartz, Mary Beth Terry	6
15	DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows 2018 ·JNCI Journal of the National Cancer Institute ·Barbara A. Cohn, Piera M. Cirillo, Mary Beth Terry	81
16	Non-invasive optical spectroscopic monitoring of breast development during puberty 2017 ·Breast Cancer Research ·Lothar Lilge, Mary Beth Terry, (unknown), Dushanthi Pinnaduwage, Gord Glendon, Danielle Hanna, (unknown), Angela R. Bradbury, Saundra S. Buys, Mary B. Daly, Esther M. John, Julia A. Knight, Irene L. Andrulis	8
17	Early life socioeconomic environment and mammographic breast density 2017 ·BMC Cancer ·Parisa Tehranifar, Barbara A. Cohn, Julie D. Flom, (unknown), Piera M. Cirillo, L. H. Lumey, Karin B. Michels, Mary Beth Terry	7
18	Serum Antioxidant Nutrients, Vitamin A, and Mortality in U.S. Adults 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Abhishek Goyal, Mary Beth Terry, Abby B. Siegel	73
19	Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer 2012 ·Cancer Prevention Research ·Katherine D. Crew, Powel H. Brown, Heather Greenlee, Therese B. Bevers, Banu Arun, Clifford A. Hudis, Heather L. McArthur, Jenny C. Chang, Mothaffar F. Rimawi, Lana A. Vornik, Terri L. Cornelison, Antai Wang, Hanina Hibshoosh, Aqeel Ahmed, Mary Beth Terry, Regina M. Santella, Scott M. Lippman, Dawn L. Hershman	76
20	Multiple Genetic Variants in Telomere Pathway Genes and Breast Cancer Risk 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Jing Shen, Marilie D. Gammon, Hui-Chen Wu, Mary Beth Terry, Qiao Wang, Patrick T. Bradshaw, Susan L. Teitelbaum, Alfred I. Neugut, Regina M. Santella	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact